Circulating Biomarkers Market Scope and Size by 2031
Biomarkers provides a powerful way to understand chronic neurological diseases with respect to applications in epidemiology, clinical trials, and other screening aspects. Circulating biomarkers majorly includes extracellular vesicles, nucleic acids, and proteins from metastatic sites.
MARKET DYNAMICS
The circulating biomarkers market is expected to witness considerable growth due to increasing adoption of biomarkers for diagnostic purpose and rising prevalence of cancer. However, high capital investment required for circulating biomarkers is likely to hamper the growth of the global circulating biomarkers market.
MARKET SCOPE
The "Circulating Biomarkers Market Analysis to 2031" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of Circulating Biomarkers Market with detailed market segmentation by product and end user. The Circulating Biomarkers Market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in Circulating Biomarkers Market and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The circulating biomarkers market is segmented on the basis of product and end user. Based on product, the market is segmented as circulating DNA, circulating tumor cells, and other. On the basis of end user, the market is segmented as hospitals, medical research center, and others.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the Circulating Biomarkers Market based on various segments. It also provides market size and forecast estimates from year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Circulating Biomarkers Market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting Circulating Biomarkers Market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Circulating Biomarkers market in these regions.
Have a question?
Mrinal
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the Circulating Biomarkers Market based on various segments. It also provides market size and forecast estimates from year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Circulating Biomarkers Market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting Circulating Biomarkers Market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Circulating Biomarkers market in these regions.
MARKET PLAYERS
The report covers key developments in the Circulating Biomarkers Market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Circulating Biomarkers Market are anticipated to have lucrative growth opportunities in the future with the rising demand for smart hospital beds in the global market. Below mentioned is the list of few companies engaged in the Circulating Biomarkers Market.
The report also includes the profiles of key players in Circulating Biomarkers Market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
- GE Healthcare
- Agilent Technologies
- Epigenomics AG
- Fluxion Biosciences
- Affymetrix
- BD
- Abbott Laboratories
- Biocept
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Circulating Biomarkers Market - By Product
1.3.2 Circulating Biomarkers Market - By End User
1.3.3 Circulating Biomarkers Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. CIRCULATING BIOMARKERS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. CIRCULATING BIOMARKERS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. CIRCULATING BIOMARKERS MARKET - GLOBAL MARKET ANALYSIS
6.1. CIRCULATING BIOMARKERS - GLOBAL MARKET OVERVIEW
6.2. CIRCULATING BIOMARKERS - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. CIRCULATING BIOMARKERS MARKET - REVENUE AND FORECASTS TO 2028 - PRODUCT
7.1. OVERVIEW
7.2. PRODUCT MARKET FORECASTS AND ANALYSIS
7.3. CIRCULATING DNA
7.3.1. Overview
7.3.2. Circulating DNA Market Forecast and Analysis
7.4. CIRCULATING TUMOR CELLS
7.4.1. Overview
7.4.2. Circulating Tumor Cells Market Forecast and Analysis
7.5. OTHER
7.5.1. Overview
7.5.2. Other Market Forecast and Analysis
8. CIRCULATING BIOMARKERS MARKET - REVENUE AND FORECASTS TO 2028 - END USER
8.1. OVERVIEW
8.2. END USER MARKET FORECASTS AND ANALYSIS
8.3. HOSPITALS
8.3.1. Overview
8.3.2. Hospitals Market Forecast and Analysis
8.4. MEDICAL RESEARCH CENTER
8.4.1. Overview
8.4.2. Medical Research Center Market Forecast and Analysis
8.5. OTHERS
8.5.1. Overview
8.5.2. Others Market Forecast and Analysis
9. CIRCULATING BIOMARKERS MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Circulating Biomarkers Market Overview
9.1.2 North America Circulating Biomarkers Market Forecasts and Analysis
9.1.3 North America Circulating Biomarkers Market Forecasts and Analysis - By Product
9.1.4 North America Circulating Biomarkers Market Forecasts and Analysis - By End User
9.1.5 North America Circulating Biomarkers Market Forecasts and Analysis - By Countries
9.1.5.1 United States Circulating Biomarkers Market
9.1.5.1.1 United States Circulating Biomarkers Market by Product
9.1.5.1.2 United States Circulating Biomarkers Market by End User
9.1.5.2 Canada Circulating Biomarkers Market
9.1.5.2.1 Canada Circulating Biomarkers Market by Product
9.1.5.2.2 Canada Circulating Biomarkers Market by End User
9.1.5.3 Mexico Circulating Biomarkers Market
9.1.5.3.1 Mexico Circulating Biomarkers Market by Product
9.1.5.3.2 Mexico Circulating Biomarkers Market by End User
9.2. EUROPE
9.2.1 Europe Circulating Biomarkers Market Overview
9.2.2 Europe Circulating Biomarkers Market Forecasts and Analysis
9.2.3 Europe Circulating Biomarkers Market Forecasts and Analysis - By Product
9.2.4 Europe Circulating Biomarkers Market Forecasts and Analysis - By End User
9.2.5 Europe Circulating Biomarkers Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Circulating Biomarkers Market
9.2.5.1.1 Germany Circulating Biomarkers Market by Product
9.2.5.1.2 Germany Circulating Biomarkers Market by End User
9.2.5.2 France Circulating Biomarkers Market
9.2.5.2.1 France Circulating Biomarkers Market by Product
9.2.5.2.2 France Circulating Biomarkers Market by End User
9.2.5.3 Italy Circulating Biomarkers Market
9.2.5.3.1 Italy Circulating Biomarkers Market by Product
9.2.5.3.2 Italy Circulating Biomarkers Market by End User
9.2.5.4 Spain Circulating Biomarkers Market
9.2.5.4.1 Spain Circulating Biomarkers Market by Product
9.2.5.4.2 Spain Circulating Biomarkers Market by End User
9.2.5.5 United Kingdom Circulating Biomarkers Market
9.2.5.5.1 United Kingdom Circulating Biomarkers Market by Product
9.2.5.5.2 United Kingdom Circulating Biomarkers Market by End User
9.2.5.6 Rest of Europe Circulating Biomarkers Market
9.2.5.6.1 Rest of Europe Circulating Biomarkers Market by Product
9.2.5.6.2 Rest of Europe Circulating Biomarkers Market by End User
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Circulating Biomarkers Market Overview
9.3.2 Asia-Pacific Circulating Biomarkers Market Forecasts and Analysis
9.3.3 Asia-Pacific Circulating Biomarkers Market Forecasts and Analysis - By Product
9.3.4 Asia-Pacific Circulating Biomarkers Market Forecasts and Analysis - By End User
9.3.5 Asia-Pacific Circulating Biomarkers Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Circulating Biomarkers Market
9.3.5.1.1 Australia Circulating Biomarkers Market by Product
9.3.5.1.2 Australia Circulating Biomarkers Market by End User
9.3.5.2 China Circulating Biomarkers Market
9.3.5.2.1 China Circulating Biomarkers Market by Product
9.3.5.2.2 China Circulating Biomarkers Market by End User
9.3.5.3 India Circulating Biomarkers Market
9.3.5.3.1 India Circulating Biomarkers Market by Product
9.3.5.3.2 India Circulating Biomarkers Market by End User
9.3.5.4 Japan Circulating Biomarkers Market
9.3.5.4.1 Japan Circulating Biomarkers Market by Product
9.3.5.4.2 Japan Circulating Biomarkers Market by End User
9.3.5.5 Rest of Asia-Pacific Circulating Biomarkers Market
9.3.5.5.1 Rest of Asia-Pacific Circulating Biomarkers Market by Product
9.3.5.5.2 Rest of Asia-Pacific Circulating Biomarkers Market by End User
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Circulating Biomarkers Market Overview
9.4.2 Middle East and Africa Circulating Biomarkers Market Forecasts and Analysis
9.4.3 Middle East and Africa Circulating Biomarkers Market Forecasts and Analysis - By Product
9.4.4 Middle East and Africa Circulating Biomarkers Market Forecasts and Analysis - By End User
9.4.5 Middle East and Africa Circulating Biomarkers Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Circulating Biomarkers Market
9.4.5.1.1 South Africa Circulating Biomarkers Market by Product
9.4.5.1.2 South Africa Circulating Biomarkers Market by End User
9.4.5.2 Saudi Arabia Circulating Biomarkers Market
9.4.5.2.1 Saudi Arabia Circulating Biomarkers Market by Product
9.4.5.2.2 Saudi Arabia Circulating Biomarkers Market by End User
9.4.5.3 Rest of Middle East and Africa Circulating Biomarkers Market
9.4.5.3.1 Rest of Middle East and Africa Circulating Biomarkers Market by Product
9.4.5.3.2 Rest of Middle East and Africa Circulating Biomarkers Market by End User
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Circulating Biomarkers Market Overview
9.5.2 South and Central America Circulating Biomarkers Market Forecasts and Analysis
9.5.3 South and Central America Circulating Biomarkers Market Forecasts and Analysis - By Product
9.5.4 South and Central America Circulating Biomarkers Market Forecasts and Analysis - By End User
9.5.5 South and Central America Circulating Biomarkers Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Circulating Biomarkers Market
9.5.5.1.1 Brazil Circulating Biomarkers Market by Product
9.5.5.1.2 Brazil Circulating Biomarkers Market by End User
9.5.5.2 Argentina Circulating Biomarkers Market
9.5.5.2.1 Argentina Circulating Biomarkers Market by Product
9.5.5.2.2 Argentina Circulating Biomarkers Market by End User
9.5.5.3 Rest of South and Central America Circulating Biomarkers Market
9.5.5.3.1 Rest of South and Central America Circulating Biomarkers Market by Product
9.5.5.3.2 Rest of South and Central America Circulating Biomarkers Market by End User
10. IMPACT OF COVID-19 PANDEMIC ON GLOBAL CIRCULATING BIOMARKERS MARKET
10.1 North America
10.2 Europe
10.3 Asia-Pacific
10.4 Rest of the World
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. CIRCULATING BIOMARKERS MARKET, KEY COMPANY PROFILES
12.1. GE HEALTHCARE
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. AGILENT TECHNOLOGIES
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. EPIGENOMICS AG
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. FLUXION BIOSCIENCES
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. AFFYMETRIX
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. BD
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. ABBOTT LABORATORIES
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. BIOCEPT
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
1. GE Healthcare
2. Agilent Technologies
3. Epigenomics AG
4. Fluxion Biosciences
5. Affymetrix
6. BD
7. Abbott Laboratories
8. Biocept
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For